Literature DB >> 28994761

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo.

Jolanta Jagodzinska1, Emmanuelle Sarzi1, Mélanie Cavalier1, Marie Seveno1, Volker Baecker2, Christian Hamel3, Marie Péquignot1, Cecile Delettre4.   

Abstract

Structural changes in the retina are common manifestations of ophthalmic diseases. Optical coherence tomography (OCT) enables their identification in vivo-rapidly, repetitively, and at a high resolution. This protocol describes OCT imaging in the mouse retina as a powerful tool to study optic neuropathies (OPN). The OCT system is an interferometry-based, non-invasive alternative to common post mortem histological assays. It provides a fast and accurate assessment of retinal thickness, allowing the possibility to track changes, such as retinal thinning or thickening. We present the imaging process and analysis with the example of the Opa1delTTAG mouse line. Three types of scans are proposed, with two quantification methods: standard and homemade calipers. The latter is best for use on the peripapillary retina during radial scans; being more precise, is preferable for analyzing thinner structures. All approaches described here are designed for retinal ganglion cells (RGC) but are easily adaptable to other cell populations. In conclusion, OCT is efficient in mouse model phenotyping and has the potential to be used for the reliable evaluation of therapeutic interventions.

Entities:  

Mesh:

Year:  2017        PMID: 28994761      PMCID: PMC5752311          DOI: 10.3791/55865

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  12 in total

Review 1.  Dominant optic atrophy.

Authors:  Guy Lenaers; Christian Hamel; Cécile Delettre; Patrizia Amati-Bonneau; Vincent Procaccio; Dominique Bonneau; Pascal Reynier; Dan Milea
Journal:  Orphanet J Rare Dis       Date:  2012-07-09       Impact factor: 4.123

2.  WFS1 in Optic Neuropathies: Mutation Findings in Nonsyndromic Optic Atrophy and Assessment of Clinical Severity.

Authors:  Joanna Grenier; Isabelle Meunier; Vincent Daien; Corinne Baudoin; François Halloy; Béatrice Bocquet; Catherine Blanchet; Cécile Delettre; Etienne Esmenjaud; Agathe Roubertie; Guy Lenaers; Christian P Hamel
Journal:  Ophthalmology       Date:  2016-07-07       Impact factor: 12.079

3.  Monitoring retinal morphologic and functional changes in mice following optic nerve crush.

Authors:  Yang Liu; Colleen M McDowell; Zhang Zhang; Holly E Tebow; Robert J Wordinger; Abbot F Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-22       Impact factor: 4.799

4.  Retinal thinning as a marker of disease progression in patients with Wolfram syndrome.

Authors:  Agnieszka Zmyslowska; Wojciech Fendler; Anna Niwald; Malgorzata Ludwikowska-Pawlowska; Maciej Borowiec; Karolina Antosik; Agnieszka Szadkowska; Wojciech Mlynarski
Journal:  Diabetes Care       Date:  2015-03       Impact factor: 19.112

Review 5.  Approach to diagnosis and management of optic neuropathy.

Authors:  Sharik Mustafa; Lekha Pandit
Journal:  Neurol India       Date:  2014 Nov-Dec       Impact factor: 2.117

Review 6.  Retinal degeneration mutants in the mouse.

Authors:  B Chang; N L Hawes; R E Hurd; M T Davisson; S Nusinowitz; J R Heckenlively
Journal:  Vision Res       Date:  2002-02       Impact factor: 1.886

7.  The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse.

Authors:  Emmanuelle Sarzi; Claire Angebault; Marie Seveno; Naïg Gueguen; Benjamin Chaix; Guy Bielicki; Nathalie Boddaert; Anne-Laure Mausset-Bonnefont; Chantal Cazevieille; Valérie Rigau; Jean-Pierre Renou; Jing Wang; Cécile Delettre; Philippe Brabet; Jean-Luc Puel; Christian P Hamel; Pascal Reynier; Guy Lenaers
Journal:  Brain       Date:  2012-12       Impact factor: 13.501

Review 8.  State-of-the-art retinal optical coherence tomography.

Authors:  Wolfgang Drexler; James G Fujimoto
Journal:  Prog Retin Eye Res       Date:  2007-08-11       Impact factor: 21.198

9.  Increased steroidogenesis promotes early-onset and severe vision loss in females with OPA1 dominant optic atrophy.

Authors:  Emmanuelle Sarzi; Marie Seveno; Claire Angebault; Dan Milea; Cecilia Rönnbäck; Melanie Quilès; Mathias Adrian; Joanna Grenier; Angélique Caignard; Annie Lacroux; Christian Lavergne; Pascal Reynier; Michael Larsen; Christian P Hamel; Cécile Delettre; Guy Lenaers; Agnès Müller
Journal:  Hum Mol Genet       Date:  2016-06-03       Impact factor: 6.150

10.  Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography.

Authors:  M Dominik Fischer; Gesine Huber; Susanne C Beck; Naoyuki Tanimoto; Regine Muehlfriedel; Edda Fahl; Christian Grimm; Andreas Wenzel; Charlotte E Remé; Serge A van de Pavert; Jan Wijnholds; Marek Pacal; Rod Bremner; Mathias W Seeliger
Journal:  PLoS One       Date:  2009-10-19       Impact factor: 3.240

View more
  3 in total

1.  Early Retinal Defects in Fmr1-/y Mice: Toward a Critical Role of Visual Dys-Sensitivity in the Fragile X Syndrome Phenotype?

Authors:  Olivier Perche; Chloé Felgerolle; Maryvonne Ardourel; Audrey Bazinet; Arnaud Pâris; Rafaëlle Rossignol; Géraldine Meyer-Dilhet; Anne-Laure Mausset-Bonnefont; Betty Hébert; David Laurenceau; Céline Montécot-Dubourg; Arnaud Menuet; Jean-Charles Bizot; Jacques Pichon; Isabelle Ranchon-Cole; Sylvain Briault
Journal:  Front Cell Neurosci       Date:  2018-04-06       Impact factor: 5.505

2.  SPACR Encoded by IMPG1 Is Essential for Photoreceptor Survival by Interplaying between the Interphotoreceptor Matrix and the Retinal Pigment Epithelium.

Authors:  Guillaume Olivier; Philippe Brabet; Nelly Pirot; Morgane Broyon; Laurent Guillou; Chantal Cazevieille; Chamroeun Sar; Melanie Quiles; Emmanuelle Sarzi; Marie Pequignot; Ervann Andreo; Agathe Roubertie; Isabelle Meunier; Agnès Muller; Vasiliki Kalatzis; Gaël Manes
Journal:  Genes (Basel)       Date:  2022-08-23       Impact factor: 4.141

3.  Topical nerve growth factor prevents neurodegenerative and vascular stages of diabetic retinopathy.

Authors:  Gianpaolo Zerbini; Silvia Maestroni; Letizia Leocani; Andrea Mosca; Michela Godi; Renata Paleari; Arianna Belvedere; Daniela Gabellini; Paola Tirassa; Valerio Castoldi; Ilaria Viganò; Silvia Galbiati; Valentina Turco; Alessandro Lambiase; Paolo Rama
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.